SCHEMBL209533

SCHEMBL209533

CC(C)(C)N1CCN(C(=O)c2ccc(-c3cc(Cl)c(C[C@@H]4CCN([C@H]5CC[C@@H](O[Si](C)(C)C(C)(C)C)CC5)C4=O)c(Cl)c3)cc2)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.33
CCR3 P51677 2/20 0.33
KCNH2 Q12809 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
FASN P49327 1/20 0.32
HRH3 Q9Y5N1 4/20 0.32
ABL1 P00519 2/20 0.32
BCR P11274 2/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
MGLL Q99685 1/20 0.32
PARP1 P09874 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
PDE5A O76074 1/20 0.32
PDE4A P27815 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209534 1.00 HRH1 (0.33) HRH1CCR3KCNH2MEN1ALDH1A1
SCHEMBL211810 1.00 HRH1 (0.33) HRH1CCR3KCNH2MEN1ALDH1A1
SCHEMBL209532 1.00 HRH1 (0.33) HRH1CCR3KCNH2MEN1ALDH1A1
SCHEMBL208996 0.92 MET (0.40) HRH3PIK3CAMTORSLC6A4MET
SCHEMBL208995 0.92 MET (0.40) HRH3PIK3CAMTORSLC6A4MET
SCHEMBL208200 0.92 HRH3 (0.40) HRH1MEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL210979 0.92 HRH3 (0.40) HRH1MEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL210980 0.92 HRH3 (0.40) HRH1MEN1ALDH1A1CYP1A2CYP2C19
SCHEMBL209200 0.91 HDAC4 (0.41) MEN1ALDH1A1CYP1A2CYP2C19KMT2A
SCHEMBL209199 0.91 HDAC4 (0.41) MEN1ALDH1A1CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HRH1 1054/4885CCR3 3385/4885KCNH2 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.